ENSC

Ensysce Biosciences, Inc. Common Stock

0.40

USD

-0.01

-3.47%

Sep 24, 15:59 UTC -4

Closed

Pre-Market

0.44

+0.04

+10.47%

Ensysce Biosciences, Inc. Common Stock Profile

About

Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is involved in developing tamper-proof opioids which prevent both drug abuse and overdoses. Ensysce Biosciences, formerly known as Leisure Acquisition Corp., is based in SAN DIEGO.

Info & Links

CEO

Lynn Kirkpatrick

Headquarters

7946 IVANHOE AVENUE, SUITE 201
LA JOLLA, CA 92037, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

Employees

Ensysce Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

8.60M

Enterprise Value

8.12M

Enterprise Value/EBITDA(ttm)

-0.64

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.85

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-280.53%

Profit Margin(ttm)

-373.54%

Return on Equity(ttm)

-2550.30%

Return on Invested Capital(ttm)

240.75%

Return on Assets(ttm)

-320.49%

Income Statement

Revenue(ttm)

4.50M

Revenue Per Share(ttm)

0.23

Gross Profit(ttm)

4.50M

EBITDA(ttm)³

-12.65M

Net Income Available to Common(ttm)

-12.62M

Diluted EPS(ttm)

-2.76

Share Statistics

Beta (5Y Monthly)

0.97

52-Week Change

-82.06%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

19.46M

Dividend Yield

0.00%

Float⁴

18.91M

% Held by Insiders

2.80%

% Held by Institutions

5.63%

Balance Sheet

Total Cash(mrq)

676.70K

Total Cash Per Share(mrq)

0.03

Total Debt(mrq)

196.80K

Total Debt/Equity(mrq)

-17.72%

Current Ratio(mrq)

0.70%

Quick Ratio(mrq)

0.70%

Book Value Per Share(mrq)

-0.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.42

Free Cash Flow(ytd)

-5.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.